We found that the PKHD1L1 mRNA expression levels were significantly lower in skin cutaneous melanoma (SKCM) and lung adenocarcinoma (LUAD) than in normal tissues. This evidence concerns the gene PKHD1L1 and lung adenocarcinoma.